Forma Therapeutics Holdings, Inc. Common Stock
FMTX
FMTX was delisted on the 13th of October, 2022.
24 hedge funds and large institutions have $1.17B invested in Forma Therapeutics Holdings, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
65.01% more ownership
Funds ownership: 0% → 65.01% (+65%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$391M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$147M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$94.3M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$86.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$77.3M |
Top Sellers
FMTX Hedge Fund Activity: Q2 2020 in Review
24 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q2 2020, worth a combined $1.17B.
Buyers outnumbered sellers: 24 funds opened new FMTX positions and 0 closed out — a net gain of 24 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $391M.
- 24 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q2 2020, up from 0 in Q1 2020.
- Funds reported $1.17B of Forma Therapeutics Holdings, Inc. Common Stock stock for Q2 2020.
- 24 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q2 2020 and 0 closed out, a net change of +24 holders.
- The largest Forma Therapeutics Holdings, Inc. Common Stock buyer in Q2 2020 was RA Capital Management, an estimated $391M added.
Based on aggregated 13F filings for Q2 2020.